Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Levallorphan

From Wikipedia, the free encyclopedia
Opioid medication

Pharmaceutical compound
Levallorphan
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • (−)-17-allylmorphinan-3-ol
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.005.273Edit this at Wikidata
Chemical and physical data
FormulaC19H25NO
Molar mass283.415 g·mol−1
3D model (JSmol)
  • Oc1ccc3c(c1)[C@@]24[C@H]([C@H](N(CC2)C\C=C)C3)CCCC4
  • InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18-,19-/m0/s1 checkY
  • Key:OZYUPQUCAUTOBP-WDSOQIARSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Levallorphan (INN,BAN;USANlevallorphan tartrate; brand namesLorfan,Naloxifan, andNaloxiphan) is anopioid modulator of themorphinan family used as anopioidanalgesic andopioid antagonist/antidote.[1][2][3] It acts as anantagonist of theμ-opioid receptor (MOR) and as anagonist of theκ-opioid receptor (KOR),[4] and as a result, blocks the effects of stronger agents with greaterintrinsic activity such asmorphine whilst simultaneously producinganalgesia.[5]

Levallorphan was formerly widely used ingeneral anesthesia, mainly to reverse therespiratory depression produced by opioid analgesics andbarbiturates used for induction ofsurgical anaesthesia whilst maintaining a degree of analgesia (via KOR agonism). It is now less commonly employed for this purpose as the newer drugnaloxone tends to be used instead. Levallorphan was also used in combination with opioid analgesics to reduce theirside effects, mainly inobstetrics, and a very small dose of levallorphan used alongside afull agonist of the MOR can produce greater analgesia than when the latter is used by itself.[6] The combination of levallorphan withpethidine (meperidine) was indeed used so frequently, a standardized formulation was made available, known asPethilorfan.[7]

As an agonist of the KOR, levallorphan can produce severe mental reactions at sufficient doses includinghallucinations,dissociation, and otherpsychotomimetic effects,dysphoria,anxiety,confusion,dizziness,disorientation,derealization, feelings ofdrunkenness,delusions, paranoia, and bizarre, unusual, or disturbingdreams.[8][9][10]

See also

[edit]

References

[edit]
  1. ^Elks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 731–.ISBN 978-1-4757-2085-3.
  2. ^Swiss Pharmaceutical Society (2000).Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers.ISBN 978-3-88763-075-1.
  3. ^Morton IK, Hall JM (6 December 2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 164–.ISBN 978-94-011-4439-1.
  4. ^Goodman & Gilman (2001).The Pharmacological Basis of Therapeutics (10th ed.). McGraw Hill Medical Publishing. p. 602.ISBN 978-0-07-135469-1.
  5. ^Codd EE, Shank RP, Schupsky JJ, Raffa RB (September 1995). "Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception".The Journal of Pharmacology and Experimental Therapeutics.274 (3):1263–70.doi:10.1016/S0022-3565(25)10630-7.PMID 7562497.
  6. ^Bullough J (October 1959)."Use of premixed pethidine and antagonists in obstetrical analgesia; with special reference to cases in which levallorphan was used".British Medical Journal.2 (5156):859–62.doi:10.1136/bmj.2.5156.859.PMC 1990381.PMID 13805887.
  7. ^Williams G, Cope I (September 1962). "An evaluation of a combination of pethidine and levallorphan ("pethilorfan") in labour".The Medical Journal of Australia.49 (2):499–503.doi:10.5694/j.1326-5377.1962.tb20494.x.PMID 14000851.
  8. ^Hall RC (6 December 2012).Psychiatric Presentations of Medical Illness: Somatopsychic Disorders. Springer Science & Business Media. pp. 364–.ISBN 978-94-011-7677-4.
  9. ^American Hospital Formulary Service Drug Information. authority of the Board of Directors of the American Society of Hospital Pharmacists. 1984. p. 664.
  10. ^Williams JB (1963).Narcotics. Wm. C. Brown Company. p. 203.
Opioids
Opiates/opium
Semisynthetic
Synthetic
Paracetamol-type
NSAIDs
Propionates
Oxicams
Acetates
COX-2 inhibitors
Fenamates
Salicylates
Pyrazolones
Others
Cannabinoids
Ion channel
modulators
Calcium blockers
Sodium blockers
Potassium openers
Myorelaxants
Others
Nervous
system
Alcohol intoxication
Barbiturate
overdose
Benzodiazepine
overdose
GHB overdose
Nerve agent /
Organophosphate
poisoning
Opioid overdose
Reversal of
neuromuscular blockade
Circulatory
system
Beta blocker
Digoxin toxicity
Anticoagulants
Other
Arsenic poisoning
Cyanide poisoning
Hydrofluoric acid
Methanol /
Ethylene glycol
poisoning
Paracetamol toxicity
(Acetaminophen)
Toxic metals (cadmium
Other
Emetic
Psychedelics
(5-HT2AR agonists)
  • For a full list of serotonergic psychedelics, see the navboxhere and the listhere instead.
Dissociatives
(NMDARantagonists)
Arylcyclo‐
hexylamines
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChRantagonists)
Cannabinoids
(CB1R agonists)
Natural
Synthetic
AM-x
CPx
HU-x
JWH-x
Misc.
  •  For a full list of cannabinoids, see the navboxhere and the listhere instead.
κORagonists
GABAARagonists
Inhalants
(mixedMoATooltip mechanism of action)
Others
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Levallorphan&oldid=1285941767"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp